Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gum Tech (GUMM) -- Ignore unavailable to you. Want to Upgrade?

To: Street Walker who wrote (93)	1/29/1999 11:56:00 AM
From: Bengalus	Read Replies (1) \| Respond to of 133

Street Walker-- Since you're a day-trader, I know you don't care about the fundamentals. You just want the stock to go up. If you guys can hype it enough, perhaps it will. But let's test your product knowledge. Compare and contrast what Zicam is alleged to do with what Cold Eeze is alleged to do. My guess is that you have no idea. All this talk of future sales is pointless when there's no way to evaluate what the product does. I repeat, when Quigley made its major move, it was in mid 1996 after a study conducted by the Cleveland Clinic appeared in the Annals of Interal Medicine, and essentially replicated an earlier study conducted by Godfrey at Dartmouth College that was also published in a major peer-reviewed journal. In other words, there was at least some tangible research to read and evaluate. Show me the Zicam articles.